CHARLOTTE, N.C., July 25, 2025 /PRNewswire/ -- The Allspring Income Opportunities Fund (NYSE American: EAD), the Allspring Multi-Sector Income Fund (NYSE American: ERC), and...
COPENHAGEN, Denmark, July 25, 2025 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, will be presenting two-year clinical efficacy data from its phase 2 trial with lead compound EVX-01 at the European Society for Medical Oncology (ESMO) Congress 2025 to be held in Berlin, Germany, from October 17-21, 2025.
Despite nearly all professional caregivers agreeing that informal caregivers can help bridge the demand of caregiving in Singapore to a certain extent (30% large,...
PARIS, FRANCE, 24 July 2025 - Ipsen announced today that the European Commission has approved Cabometyx® (cabozantinib) for adult patients with unresectable or metastatic, well differentiated pancreatic (pNET) and extra-pancreatic (epNET) neuroendocrine tumors who have progressed following at least one prior systemic therapy other than somatostatin analogues.
"Christmas in July" event celebrates historic first for Nevada's Humboldt-Toiyabe National Forest
LAS VEGAS, July 24, 2025 /PRNewswire/ -- For the first time in history, the...
The presentation will include data from over 90 patients in both the plaque brachytherapy and enucleation-eligible cohortsDarovasertib has received U.S. FDA Breakthrough Therapy Designation...
New Funding Opportunity Seeks Catalytic Solutions to Address Data Demand
SAN DIEGO, July 23, 2025 /PRNewswire/ -- Cambiar Education, with support from the Walton Family...
ATLANTA, July 23, 2025 /PRNewswire/ -- The CDC Foundation today announced the recipients of two esteemed awards recognizing outstanding contributions to public health and health...